naloxonazine
SMILES | C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2/C(=N\N=C/2\CC[C@@]3([C@@]56[C@H]2Oc2c6c(C[C@H]3N(CC5)CC=C)ccc2O)O)/CC4)c(cc1)O)O |
InChIKey | AJPSBXJNFJCCBI-HNJBNLCWSA-N |
Chemical properties
Hydrogen bond acceptors | 10 |
Hydrogen bond donors | 4 |
Rotatable bonds | 5 |
Molecular weight (Da) | 650.3 |
Drug properties
Molecular type | Small molecule |
Endogenous/Surrogate | Surrogate |
Approved drug | No |
Database connections
Bioactivities
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
δ | OPRD | Human | Opioid | A | pKi | 7.32 | 7.32 | 7.32 | ChEMBL |
κ | OPRK | Human | Opioid | A | pKi | 7.47 | 7.47 | 7.47 | ChEMBL |
μ | OPRM | Human | Opioid | A | pKi | 8.5 | 8.62 | 8.84 | ChEMBL |
μ | OPRM | Mouse | Opioid | A | pKi | 10.3 | 10.3 | 10.3 | Guide to Pharmacology |
Receptor | Activity | Source | |||||||
---|---|---|---|---|---|---|---|---|---|
GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
δ | OPRD | Human | Opioid | A | pIC50 | 6.87 | 6.87 | 6.87 | ChEMBL |
κ | OPRK | Human | Opioid | A | pIC50 | 7.07 | 7.07 | 7.07 | ChEMBL |
μ | OPRM | Human | Opioid | A | pIC50 | 8.14 | 8.14 | 8.14 | ChEMBL |